v3.26.1
Stockholders’ Deficit (Tables)
3 Months Ended
Mar. 31, 2026
Equity [Abstract]  
Schedule of Stock Based Compensation Expense Recognized for Officer and Director Arrangements

The following table summarizes stock-based compensation expense recognized for all officer and director arrangements for the three months ended March 31, 2026 and 2025:

  

   March 31, 2026   March 31, 2025 
Chief Financial Officer  $-   $119,770 
Board of Directors   49,895    35,349 
Total  $49,895   $155,119 
Schedule of Non-vested Shares Related Parties

The following is a summary of the Company’s non-vested shares at March 31, 2026 and December 31, 2025.

 

       Weighted Average 
Non-Vested Shares  Number of Shares   Grant Date Fair Value 
Balance - December 31, 2024   139,640   $5.03 
Granted   150,000    3.16 
Vested   (88,880)   4.77 
Cancelled/Forfeited   -    - 
Balance - December 31, 2025   200,760    4.00 
Granted   -      
Vested   -      
Cancelled/Forfeited   -      
Balance - March 31, 2026   200,760   $4.00 
           
Unrecognized Compensation  $457,367      
           
Weighted average period (years)   2.33      
Schedule of Stock Option Transactions

Stock option transactions for the three months ended March 31, 2026 and the year ended December 31, 2025 are summarized as follows:

 

           Weighted       Weighted 
       Weighted   Average       Average 
       Average   Remaining   Aggregate   Grant 
   Number of   Exercise    Contractual   Intrinsic   Date 
Stock Options  Options   Price   Term (Years)   Value   Fair Value 
Outstanding - December 31, 2024   1,166,081   $2.37    6.85   $-      
Vested and Exercisable - December 31, 2024   1,166,081   $2.37    6.85   $-      
Granted   1,144,116   $1.75             $1.49 
Exercised   -   $-                
Cancelled/Forfeited   (17,253)  $1.78                
Outstanding - December 31, 2025   2,292,944   $2.06    6.43   $-      
Vested and Exercisable - December 31, 2025   2,292,944   $2.06    6.43   $-      
Granted   -   $-             $- 
Exercised   -   $-                
Cancelled/Forfeited   (324,750)  $2.51                
Outstanding - March 31, 2026   1,968,194   $1.99    6.22   $-      
Vested and Exercisable - March 31, 2026   1,968,194   $1.99    6.22   $-      
Schedule of Fair Value of Stock Options

The fair value of these stock options was determined using the Black-Scholes option pricing model with the following inputs:

 

Expected term   7 years 
Expected volatility   103%
Expected dividends   0%
Risk free interest rate   3.88%
Schedule of Stock Based Compensation Expense

Stock-based compensation expense related to stock options for the three months ended March 31, 2026 and 2025, was as follows:

Schedule of Stock Based Compensation Expense

 

 Three Months Ended March 31,
 2026    2025 
$-   $- 
Schedule of Warrants Activity

Warrant activity for the three months ended March 31, 2026 and the year ended December 31, 2025 are summarized as follows:

 

           Weighted     
           Average     
       Weighted   Remaining   Aggregate 
   Number of   Average   Contractual   Intrinsic 
Warrants  Warrants   Exercise Price   Term (Years)   Value 
Outstanding - December 31, 2024   96,000   $4.73    0.37   $- 
Vested and Exercisable - December 31, 2024   96,000   $4.73    0.37   $- 
Granted   730,000   $5.86           
Exercised   -   $-           
Cancelled/Forfeited   (96,000)  $4.73           
Outstanding - December 31, 2025   730,000   $5.86    4.30   $- 
Vested and Exercisable - December 31, 2025   730,000   $5.86    4.30   $- 
Granted   435,000   $1.27           
Exercised   -   $-           
Cancelled/Forfeited   -   $-           
Outstanding - March 31, 2026   1,165,000   $4.14    4.38   $- 
Vested and Exercisable - March 31, 2026   1,165,000   $4.14    4.38   $-